Shares of Comp En De Mn Cemig ADS (NYSE:CIG - Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.84 and traded as high as $1.97. Comp En De Mn Cemig ADS shares last traded at $1.96, with a volume of 3,864,144 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Bank of America downgraded shares of Comp En De Mn Cemig ADS from a "neutral" rating to an "underperform" rating in a report on Tuesday, April 1st.
Read Our Latest Stock Analysis on CIG
Comp En De Mn Cemig ADS Stock Performance
The firm's 50 day moving average price is $1.85 and its two-hundred day moving average price is $1.84. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a market cap of $5.51 billion, a PE ratio of 4.14 and a beta of 1.07.
Comp En De Mn Cemig ADS Company Profile
(
Get Free Report)
Companhia Energética de Minas Gerais, through its subsidiaries, engages in the generation, transmission, distribution, and sale of electricity in Brazil. The company generates electricity through renewable energy sources, such as water, wind, sun, and biomass; or non-renewable sources, including fossil and nuclear fuels.
See Also
Before you consider Comp En De Mn Cemig ADS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Comp En De Mn Cemig ADS wasn't on the list.
While Comp En De Mn Cemig ADS currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.